Psyence Biomedical (PBM) Invested Capital (2024 - 2025)
Psyence Biomedical (PBM) recorded quarterly Invested Capital of $7.1 million in Q1 2025, up 317507.4% quarter-over-quarter from -$2242.0 in Q3 2024, and up 1397.54% on a YoY basis from $475197.0 in Q1 2024.
Psyence Biomedical (PBM) Invested Capital (2024 - 2025) Analysis & Trends
Psyence Biomedical's Invested Capital history runs 2 years deep, the most recent figure standing at $7.1 million for Q1 2025.
- In Q1 2025, Invested Capital rose 1397.54% year-over-year to $7.1 million; the TTM figure through Mar 2025 stood at $7.1 million (up 1397.54% YoY), while the FY2025 annual figure was $7.1 million, up 1397.54% from the prior year.
- Invested Capital was $7.1 million for Q1 2025 at Psyence Biomedical, up from -$2242.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $7.1 million in Q1 2025 to a low of -$2242.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 502.95 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 31.42 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 7.12 Mn |
| Sep 30, 2024 | -2,242.00 |
| Mar 31, 2024 | 475,197.00 |